Yanming Wei

Mr. Yanming Wei


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2018 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
YWYanming Wei
Yanming Wei
YWYong-Hui Wang
Yong-Hui Wang
HXHui-Qing Xue
Hui-Qing Xue
ZLZhi-Hua Luan
Zhi-Hua Luan
BLBi-Wang Liu
Bi-Wang Liu
JRJin-Hong Ren
Jin-Hong Ren

30 October 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
OTOusman Tamgue
Ousman Tamgue
CCCheng-Sen Chai
Cheng-Sen Chai
LHLin Hao
Lin Hao
JZJohn-Clotaire Daguia Zambe
John-Clotaire Daguia Zambe
WHWei-Wei Huang
Wei-Wei Huang
YWYanming Wei
Yanming Wei
Triptolide Inhibits Histone Methyltransferase EZH2 and Modulates the Expression of Its Target Genes in Prostate Cancer Cells EZH2;EZH2 target genes;prostate cancer (PCa);Triptolide; The histone methyltransferase EZH2 (enhancer of zeste homolog 2) plays critical roles in prostate cancer (PCa) development and is a potential target for PCa treatment. Triptolide possesses anti-tumor activity, but it is unknown whether its therapeutic effect relates with EZH2 in PCa. Here we described EZH2 as a target for Triptolide in PCa cells. Our data showed that Triptolide suppressed PCa cell growth and reduced the expression of EZH2. Overexpression of EZH2 attenuated the Triptolide induced cell growth inhibition. Moreover, Triptolide treatment of PC-3 cells resulted in elevated mRNA levels of target genes (ADRB2, CDH1, CDKN2A and DAB2IP) negatively regulated by EZH2 as well as reduced mRNA levelsan of EZH2 positively regulated gene (cyclin D1). Our findings suggest the PCa cell growth inhibition mediated by Triptolide might be associated with downregulation of EZH2 expression and the subsequent modulation of target genes.

25 July 2019 in International Journal of Toxicology
Verified
Journal Article
Closed access
PDF file
YWYanming Wei
Yanming Wei
ZLZhi Hua Luan
Zhi Hua Luan
BLBi Wang Liu
Bi Wang Liu
YWYong Hui Wang
Yong Hui Wang
YCYin Xia Chang
Yin Xia Chang
JRJin Hong Ren
Jin Hong Ren
Triptolide is a major active ingredient isolated from the traditional Chinese herb Tripterygium wilfordii Hook F. However, its use in clinical practice is limited due to its severe hepatotoxicity. Autophagy, a highly conserved intracellular process, is essential for maintaining cytoplasmic homeostasis. Considering that abnormalities in autophagy are closely associated with drug-mediated hepatotoxicity, we applied human normal liver HL7702 cells to elucidate the roles of autophagy in triptolide-induced hepatotoxicity. Our study revealed that triptolide was cytotoxic to HL7702 cells. It markedly increased autophagosome formation and expression of autophagy-related proteins, namely Beclin1 and microtubule-associated protein 1 light chain 3II, and induced oxidative stress. These proautophagic effects were counteracted by pretreatment with N-acetylcysteine, a reactive oxygen species scavenger. Moreover, the pharmacological suppression of autophagy further exacerbated triptolide-elicited decrease in cell viability, increase in lactate dehydrogenase leakage, and activation of apoptosis proteases (caspase 3 and caspase 9). Our findings suggest that triptolide-induced oxidative stress consequently enhances autophagic activity, and autophagy is a cytoprotective mechanism against triptolide-induced cytotoxicity in HL7702 cells.

1 January 2014 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
YWYanming Wei
Yanming Wei
Previous studies have confirmed that the beclin 1 complex plays a key role in the initial stage of autophagy and deregulated autophagy might involve in amyotrophic lateral sclerosis. However, the mechanism underlying altered autophagy associated with the beclin 1 complex remains unclear. In this study, we transfected the Cu/Zn superoxide dismutase 1 G93A mutant protein into the motor neuron-like cell line NSC34 cultured in vitro. Western blotting and co-immunoprecipitation showed that the Cu/Zn superoxide dismutase 1 G93A mutant enhanced the turnover of autophagic marker microtubule-associated protein light chain 3II (LC3II) and stimulated the conversion of EGFP-LC3I to EGFP-LC3II, but had little influence on the binding capacity of the autophagy modulators ATG14L, rubicon, UVRAG, and hVps34 to beclin 1 during autophagosome formation. These results suggest that the amyotrophic lateral sclerosis-linked Cu/Zn superoxide dismutase 1 G93A mutant can upregulate autophagic activity in NSC34 cells, but that this does not markedly affect beclin 1 complex components.

20 April 2023 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
CZCaixia Zhang
Caixia Zhang
WWWeiyan Wang
Weiyan Wang
CDChenhui Du
Chenhui Du
HLHuifang Li
Huifang Li
KZKun Zhou
Kun Zhou
YWYanming Wei
Yanming Wei
Celastrol, a natural compound extracted from the traditional Chinese medicinal herb Tripterygium wilfordii Hook F, possesses broad‑spectrum pharmacological properties. Autophagy is an evolutionarily conserved catabolic process through which cytoplasmic cargo is delivered to the lysosomes for degradation. Autophagy dysregulation contributes to multiple pathological processes. Therefore, targeting autophagic activity is a promising therapy for various diseases, as well as a drug‑development strategy. According to previous studies, autophagy is specifically targeted and may be altered in response to celastrol treatment, highlighting that autophagy modulation is an important mechanism underlying the therapeutic efficacy of celastrol for the treatment of various diseases. The present study summarizes the currently available information regarding the role of autophagy in the effect of celastrol to exert anti‑tumor, anti‑inflammatory, immunomodulatory, neuroprotective, anti‑atherosclerosis, anti‑pulmonary fibrosis and anti‑macular degeneration activities. The diverse signaling pathways involved are also analyzed to provide insight into the mechanisms of action of celastrol and thereby pave the way for establishing celastrol as an efficacious autophagy modulator in clinical practice.

20 May 2025 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
SLShan Liu
Shan Liu
YSYuerui Su
Yuerui Su
BHBo Han
Bo Han
LYLiang Yin
Liang Yin
HLHuifang Li
Huifang Li
YWYanming Wei
Yanming Wei